Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

Clinical trial NCT05305612 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05305612
Sponsor: National Institute of Cardiology, Warsaw, Poland
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Mitral Regurgitation Atrial Fibrillation Anticoagulation

Start date: 2022-03-13
Primary completion: 2025-05-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.